Figure 5From: The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitroSensitivity to NSAIDs is not affected by CD34 status in (A) KTOSA5 cells or (B) CSKOS cells. Cells were treated with the indicated doses of either mavacoxib or carprofen and cell viability was assayed 48 hours after treatment.Back to article page